U.S. Markets close in 2 hrs 45 mins

Axsome Therapeutics, Inc. (AXSM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
51.62-1.82 (-3.41%)
As of 1:11PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close53.44
Open53.48
Bid51.37 x 1100
Ask51.58 x 1100
Day's Range51.13 - 54.37
52 Week Range49.12 - 109.53
Volume105,242
Avg. Volume310,430
Market Cap1.931B
Beta (5Y Monthly)2.54
PE Ratio (TTM)N/A
EPS (TTM)-2.77
Earnings DateMay 06, 2021 - May 10, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est143.85
  • Why Is Axsome (AXSM) Down 19.9% Since Last Earnings Report?
    Zacks

    Why Is Axsome (AXSM) Down 19.9% Since Last Earnings Report?

    Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Read This Before Selling Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares
    Simply Wall St.

    Read This Before Selling Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shares

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...

  • Motley Fool

    1 Green Flag for Axsome Therapeutics

    Axsome Therapeutics (NASDAQ: AXSM) is approaching that important day in the life of a biotech when it shifts from unprofitable company to one that is marketing pharmaceuticals to the public. This specialist in drugs for the central nervous system is applying for two new drug applications with the Food and Drug Administration in 2021, and has two additional drugs just a year or two away from market. In this video clip from Motley Fool Live, recorded March 5, Corinne Cardina, bureau chief of healthcare and cannabis at Fool.com, and Motley Fool contributor Taylor Carmichael discuss Axsome.